1427046-38-5

Basic information

• Product Name: 4-methylpentanoic acid 7-[4-(4-benzo[b]thiophene-4-ylpiperazin-1-yl)butoxy]-2-oxo-2H-quinoline-1-ylmethyl ester
• Synonyms: 4-methylpentanoic acid 7-[4-(4-benzo[b]thiophene-4-ylpiperazin-1-yl)butoxy]-2-oxo-2H-quinoline-1-ylmethyl ester
• CAS NO: 1427046-38-5
• Molecular Weight: 561.745
• Mol File: 1427046-38-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-methylpentanoic acid 7-[4-(4-benzo[b]thiophene-4-ylpiperazin-1-yl)butoxy]-2-oxo-2H-quinoline-1-ylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-methylpentanoic acid 7-[4-(4-benzo[b]thiophene-4-ylpiperazin-1-yl)butoxy]-2-oxo-2H-quinoline-1-ylmethyl ester(1427046-38-5)
• EPA Substance Registry System: 4-methylpentanoic acid 7-[4-(4-benzo[b]thiophene-4-ylpiperazin-1-yl)butoxy]-2-oxo-2H-quinoline-1-ylmethyl ester(1427046-38-5)

Safety Data

• Hazardous Substances Data: 1427046-38-5(Hazardous Substances Data)

Upstream product

• 17402-83-4 benzo[B]thiophen-4-ylamine 

Relevant articles and documents

Brexpiprazole derivative and preparation method thereof

The invention provides a brexpiprazole derivative, and a preparation method thereof. According to the chemical structure of the brexpiprazole derivative, the brexpiprazole derivative is prepared through following steps: brexpiprazole, and (HCHO) are reacted in the presence of a first alkaline catalyst to prepare N-hydroxymethyl brexpiprazole; and then N-hydroxymethyl brexpiprazole and an alkylformyl chloride compound are reacted in the presence of a second alkaline catalyst to obtain the brexpiprazole derivative. The brexpiprazole derivative is long in half life, and is capable of reducingmedicine administration frequency; and the brexpiprazole derivative prepared using the preparation method is low in impurity content and cost.